Your browser doesn't support javascript.
loading
Synthesis and evaluation of anthranilamide-based derivatives as FXa inhibitors.
Huang, Changjiang; Wang, Wenzhi; Li, Yao; Zhang, Shijun; Meng, Fancui; Xu, Weiren; Yuan, Jing; Chen, Ligong.
Afiliação
  • Huang C; School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
  • Wang W; Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin, China.
  • Li Y; School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.
  • Zhang S; Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin, China.
  • Meng F; Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin, China.
  • Xu W; Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin, China.
  • Yuan J; Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin, China.
  • Chen L; Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin, China.
Oncotarget ; 8(23): 37186-37199, 2017 Jun 06.
Article em En | MEDLINE | ID: mdl-28415603

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Fator Xa / Ortoaminobenzoatos / Inibidores do Fator Xa / Anticoagulantes Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Fator Xa / Ortoaminobenzoatos / Inibidores do Fator Xa / Anticoagulantes Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos